Stoke Therapeutics Inc (NASDAQ:STOK)

13.60
Delayed Data
As of Jun 24
 -0.33 / -2.37%
Today’s Change
9.55
Today|||52-Week Range
36.20
-43.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2018
Quarter 1
2019

--

--
AssetsCash--98.7M----
 
 
Short Term Investment Cash10.4M-6.7M----
 
 
 
Cash & Short Term Investments--98.7M----
 
 
 
ReceivablesReceivables--196.0K----
 
 
 
InventoriesInventories--0.00------
 
Current AssetsOther Current Assets--1.3M----
 
 
Current Assets--100.2M----
 
 
 
Total AssetsOther Assets--1.1M----
 
 
Total Assets--102.9M----
 
 
 
LiabilitiesAccounts Payable--1.1M----
 
 
Accrued Expenses--1.8M----
 
 
Other Current Liabilities--1.8M----
 
 
Other Liabilities--3.3M----
 
 
 
Total LiabilitiesOther Liabilities--10.0K----
 
 
Total Liabilities--3.4M----
 
 
 
EquityMinority Interest0.000.00------
Preferred Stock--23.0K----
 
 
Common Equity--99.6M----
 
 
Total Shareholder Equity--99.6M----
 
 
 
Share InformationCommon Shares Outstanding--31.3M----
 
 
 
Addtl. Info.No data currently available for this section.